Evidence map›Paper›PMID 23555210›Full record

ArticlePLoS computational biology2013

Bayesian estimation of mixture models with prespecified elements to compare drug resistance in treatment-naïve and experienced tuberculosis cases.

Alane Izu, Ted Cohen, Victor Degruttola

Abstract read
In one paragraph

Article in PLoS computational biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Mutations inInfection and drug resistance · 2026
    Article
  2. Article
  3. Bayesian Calibration to Address the Challenge of Antimicrobial Resistance: A Review.IEEE access : practical innovations, open solutions · 2024
    Article
  4. Article
  5. Isoniazid-resistant tuberculosis: a cause for concern?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2017
    Review
  6. Origin and proliferation of multiple-drug resistance in bacterial pathogens.Microbiology and molecular biology reviews : MMBR · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alane IzuDepartment of Science and Technology/National Research Foundation, Vaccine Preventable Diseases and Respiratory & Meningeal Pathogens Research Unit, University of Witwatersrand, Faculty of Health Science, Johannesburg, Gauteng, South Africa. izua@rmpru.co.za
Ted Cohen
Victor Degruttola

Funding

BIOSTATISTICS/EPIDEMIOLOGY TRAINING GRANTS IN AIDST32AI007358 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Michael David Hughes · 1989 to 2026
$12.4M
Prevalence, risk factors and consequences of complex M. Tuberculosis infectionsDP2OD006663 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI COHEN, THEODORE H · 2010 to 2010
$2.7M
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTST35ES007293 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BETENSKY, REBECCA A. · 1995 to 2009
$171k
NIAID NIH HHS 2 T32 AI 7358-21NIAID NIH HHS T32 AI007358NIEHS NIH HHS 5 T35 ES 7293-9NIEHS NIH HHS T35 ES007293NIH HHS DP2 OD006663NIH HHS DP2OD006663PHS HHS R01 51164
6 · The paper itself

Abstract

We propose a Bayesian approach for estimating branching tree mixture models to compare drug-resistance pathways (i.e. patterns of sequential acquisition of resistance to individual antibiotics) that are observed among Mycobacterium tuberculosis isolates collected from treatment-naïve and treatment-experienced patients. Resistant pathogens collected from treatment-naïve patients are strains for which fitness costs of resistance were not sufficient to prevent transmission, whereas those collected from treatment-experienced patients reflect both transmitted and acquired resistance, the latter of which may or may not be associated with lower transmissibility. The comparison of the resistance pathways constructed from these two groups of drug-resistant strains provides insight into which pathways preferentially lead to the development of multiple drug resistant strains that are transmissible. We apply the proposed statistical methods to data from worldwide surveillance of drug-resistant tuberculosis collected by the World Health Organization over 13 years.

Indexed as

Models, BiologicalAntitubercular AgentsBayes TheoremComputational BiologyDatabases, FactualHumansMarkov ChainsMicrobial Sensitivity TestsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular Agents

Identifiers

PMID23555210
PMCPMC3605089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.